Business Context and Reporting Period
This Form 10-Q covers the quarterly period ended September 30, 2006 for Rambus Inc., a company that designs, develops, and licenses chip interface technologies. The filing includes significant restatements of previously issued financial statements for periods ending September 30, 2005, and prior, due to an Audit Committee investigation into historical stock option granting practices. The investigation revealed that actual grant dates for many options differed from stated dates, requiring the recognition of additional stock-based compensation expense.
Key Financial Metrics
| Metric | Three Months Ended Sep 30, 2006 | Nine Months Ended Sep 30, 2006 | Three Months Ended Sep 30, 2005 (Restated) | Nine Months Ended Sep 30, 2005 (Restated) |
|---|---|---|---|---|
| Total Revenues | $45.9 million | $142.7 million | $36.0 million | $115.6 million |
| Net Income (Loss) | $(22.6) million | $(15.9) million | $11.7 million | $23.5 million |
| Operating Income (Loss) | $(25.8) million | $(39.4) million | $(0.5) million | $1.1 million |
| Cash and Cash Equivalents | $134.8 million | (Balance Sheet Item) | ||
| Marketable Securities | $286.5 million | (Balance Sheet Item) | ||
| Convertible Notes (Debt) | $160.0 million | (Balance Sheet Item) | ||
| Net Cash Provided by Operating Activities | $39.0 million (9 months) | $22.8 million (9 months) |
Note: The company reported a net loss for the current period primarily driven by "Costs of restatement and related legal activities" totaling $23.8 million for the quarter and $25.7 million for the nine months.
Material Changes vs. Prior Period
- Revenue Growth: Total revenues increased 27.5% for the quarter and 23.4% for the nine months compared to the prior year. Royalties grew significantly (48.2% for the quarter), driven by new licensees (Fujitsu, Qimonda, AMD), while contract revenues declined.
- Profitability Decline: The company shifted from profitability in the prior year to a significant net loss in 2006. This is largely attributable to a new line item for restatement costs ($23.8 million in Q3) and increased stock-based compensation due to the adoption of SFAS 123(R) and the restatement adjustments.
- Expense Increases: Research and development expenses rose 39.4% for the quarter, and Marketing, General, and Administrative expenses rose 31.0%, both heavily influenced by increased stock-based compensation and litigation costs.
- Interest Income: Interest and other income decreased significantly (78.8% for the quarter) compared to 2005, which included one-time gains from the repurchase of convertible notes.
Guidance, Outlook, Risks, and Unusual Items
Restatement and Investigation
The filing is dominated by the restatement of financials due to stock option backdating. The Audit Committee concluded that retroactive pricing of options was intentional in many instances. The company recorded an additional $169.4 million in pre-tax stock-based compensation expense for the period from 1997 to 2005. For the nine months ended September 30, 2006, an additional $5.8 million in expense was recorded under SFAS 123(R) related to these remeasured options.
Legal and Regulatory Risks
- Convertible Notes Default: The company received a notice of default and subsequent acceleration of its $160 million zero-coupon convertible senior notes due to the failure to file timely SEC reports. The company believes it has adequate resources to pay the principal and accrued interest.
- FTC and European Commission: The FTC issued a remedy order capping royalty rates for certain SDRAM products. The European Commission issued a Statement of Objections alleging competition law violations. These actions could limit the company's ability to enforce patents and collect royalties.
- Litigation: The company is involved in extensive litigation with major semiconductor manufacturers (Hynix, Micron, Samsung, Nanya) regarding patent infringement and antitrust claims. A class action lawsuit regarding the stock option investigation has reached a preliminary settlement agreement in principle for $18.0 million.
- Nasdaq Delisting: The company is not in compliance with Nasdaq listing requirements due to late filings but has been granted an extension until October 17, 2007, to become current.
Unusual Items
The "Costs of restatement and related legal activities" line item is a non-recurring expense specific to the stock option investigation, including legal fees, audit costs, and an $18.0 million accrual for the potential class action settlement.
Investor Verification Checklist
- Restatement Impact: Verify the full extent of the $169.4 million cumulative stock-based compensation adjustment and its effect on historical earnings per share.
- Convertible Notes Status: Confirm the company's ability to satisfy the accelerated $160 million debt obligation and the status of negotiations with the trustee.
- FTC Remedy Order: Assess the financial impact of the FTC-imposed royalty caps on future revenue streams from SDRAM and DDR SDRAM products.
- Litigation Exposure: Monitor the outcome of the coordinated trials with Hynix, Micron, Samsung, and Nanya, and the final approval of the $18.0 million class action settlement.
- Nasdaq Compliance: Track the company's progress in filing delinquent reports to avoid delisting from the Nasdaq Global Select Market.
- Customer Concentration: Review the dependency on top licensees (Fujitsu, Elpida, Qimonda, AMD), which accounted for 75% of revenue in the quarter.